Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor.
Burdick
J S
JS
Department of Medicine, University of Texas Southwestern Medical Center, Dallas, USA.
Chung
E
E
Tanner
G
G
Sun
M
M
Paciga
J E
JE
Cheng
J Q
JQ
Washington
K
K
Goldenring
J R
JR
Coffey
R J
RJ
D000707:Anaphylaxis / Q000139:chemically induced; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003287:Contrast Media / Q000009:adverse effects; D066246:ErbB Receptors / Q000032:analysis / Q000276:immunology*; D017809:Fatal Outcome; D005753:Gastric Mucosa / Q000737:chemistry / Q000473:pathology; D005758:Gastritis, Hypertrophic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications; D008297:Male; D008875:Middle Aged; D010295:Parietal Cells, Gastric / Q000473:pathology; D011230:Precancerous Conditions / Q000150:complications / Q000188:drug therapy*; D014839:Vomiting / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D003287:Contrast Media; D066246:ErbB Receptors